influenza-x

Identification of diagnostic and prognostic biomarkers, and candidate focused brokers for hepatitis B virus-associated early stage hepatocellular carcinoma based mostly on RNA-sequencing information

 

  • Major liver most cancers is a quickly progressing neoplasm with excessive morbidity and mortality charges. The current research aimed to determine potential diagnostic and prognostic biomarkers, and candidate focused brokers for hepatitis B virus (HBV)-associated early stage hepatocellular carcinoma (HCC). The gene expression profiles had been extracted from the Gene Expression Omnibus database.

 

  • Differentially expressed genes (DEGs), hub genes and the enrichment of signaling pathways had been filtered out through a high-throughput sequencing technique. The affiliation between hub genes and the results of the irregular expression of hub genes on the speed of genetic variation, total survival (OS), relapse-free survival (RFS), progression-free survival (PFS) and disease-free survival (DSS) of sufferers with HCC, in addition to pathological stage and grade, had been analyzed utilizing completely different databases. A complete of 1,582 DEGs had been recognized.

 

 

  • Gene Ontology evaluation revealed that the DEGs had been primarily concerned within the ‘oxidation-reduction course of’, ‘steroid metabolic course of’, ‘metabolic course of’ and ‘fatty acid beta-oxidation’. Enrichment evaluation of Kyoto Encyclopedia of Genes and Genomes pathways revealed that the DEGs had been primarily related to ‘metabolic pathways’, ‘PPAR signaling pathway’, ‘fatty acid degradation’ and the ‘cell cycle’.

 

  • A complete of Eight hub genes had been extracted. Moreover, the irregular expression ranges of hub genes had been intently related to the OS, RFS, PFS and DSS of sufferers, the pathological stage and the grade. Moreover, irregular expression ranges of the Eight hub genes had been present in >30% of all samples.

 

 

  • A number of small molecular compounds which will reverse the altered DEGs had been recognized based mostly on Connectivity Map evaluation, together with phenoxybenzamine, GW-8510, resveratrol, 0175029-0000 and daunorubicin. In conclusion, the dysfunction of fats metabolic pathways, the cell cycle, oxidation-reduction processes and viral carcinogenesis might serve vital roles within the incidence of HBV-associated early stage HCC. The recognized Eight hub genes might act as strong biomarkers for prognosis and prognosis. Some small molecular compounds could also be promising focused brokers in opposition to HBV-associated early stage HCC.

 

influenza-x

influenza-x

PEG3 Antibody

CSB-PA022042-
EUR 335
Description: A polyclonal antibody against PEG3. Recognizes PEG3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

PEG3 Antibody

CSB-PA022042-100ul 100ul
EUR 316
Description: A polyclonal antibody against PEG3. Recognizes PEG3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

PEG3 Antibody

1-CSB-PA030033
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against PEG3. Recognizes PEG3 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

PEG3 Antibody

43302-100ul 100ul
EUR 252

PEG3 Antibody

AF9152 200ul
EUR 304
Description: PEG3 Antibody detects endogenous levels of total PEG3.

PEG3 Antibody

ABF9152 100 ug
EUR 438

PEG3 antibody

70R-32122 100 ug
EUR 327
Description: Rabbit polyclonal PEG3 antibody

PEG3 Polyclonal Antibody

ES6567-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against PEG3 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

PEG3 Polyclonal Antibody

ES6567-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against PEG3 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

PEG3 Polyclonal Antibody

ABP55568-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of PEG3 from Human. This PEG3 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PEG3 at AA range: 1010-1090

PEG3 Polyclonal Antibody

ABP55568-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of PEG3 from Human. This PEG3 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PEG3 at AA range: 1010-1090

PEG3 Polyclonal Antibody

ABP55568-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of PEG3 from Human. This PEG3 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PEG3 at AA range: 1010-1090

Anti-PEG3 Antibody

A02541 100ul
EUR 397
Description: Rabbit Polyclonal PEG3 Antibody. Validated in WB and tested in Human.

Anti-PEG3 antibody

STJ95024 200 µl
EUR 197
Description: Rabbit polyclonal to PEG3.

Anti-PEG3 antibody

STJ114545 100 µl
EUR 277
Description: In human, ZIM2 and PEG3 are treated as two distinct genes though they share multiple 5' exons and a common promoter and both genes are paternally expressed (PMID:15203203). Alternative splicing events connect their shared 5' exons either with the remaining 4 exons unique to ZIM2, or with the remaining 2 exons unique to PEG3. In contrast, in other mammals ZIM2 does not undergo imprinting and, in mouse, cow, and likely other mammals as well, the ZIM2 and PEG3 genes do not share exons. Human PEG3 protein belongs to the Kruppel C2H2-type zinc finger protein family. PEG3 may play a role in cell proliferation and p53-mediated apoptosis. PEG3 has also shown tumor suppressor activity and tumorigenesis in glioma and ovarian cells. Alternative splicing of this PEG3 gene results in multiple transcript variants encoding distinct isoforms.

PEG3 Conjugated Antibody

C34056 100ul
EUR 397

NH2-PEG3

HY-W007545 100mg
EUR 108

PEG3 siRNA

20-abx928229
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

PEG3 siRNA

20-abx928230
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

Boc-NH-PEG3

HY-W017772 100mg
EUR 142

Amine-PEG3-Biotin

HY-111377 10mg
EUR 211

VH032-PEG3-acetylene

HY-128767 5mg
EUR 113

N3-PEG3-CH2COOH

HY-42637 100mg
EUR 153

NHS-PEG3-NHS

ADC-L-121 unit Ask for price

OH-PEG3-Tos

20-abx085425
  • EUR 648.00
  • EUR 1233.00
  • 1 g
  • 5 g

Tos-PEG3-Tos

20-abx085426
  • EUR 217.00
  • EUR 272.00
  • 1 g
  • 25 g

COOH-PEG3-COOH

20-abx085430
  • EUR 676.00
  • EUR 843.00
  • 1 g
  • 5 g

PEG3 Rabbit pAb

A12671-100ul 100 ul
EUR 308

PEG3 Rabbit pAb

A12671-200ul 200 ul
EUR 459

PEG3 Rabbit pAb

A12671-20ul 20 ul
EUR 183

PEG3 Rabbit pAb

A12671-50ul 50 ul
EUR 223

propargyl-PEG3-Acid

20-abx180861
  • EUR 509.00
  • EUR 690.00
  • 0.5 g
  • 1 g

N3-PEG3-NH2

20-abx186135
  • EUR 272.00
  • EUR 467.00
  • 1 g
  • 5 g

N3-PEG3-OH

20-abx186195
  • EUR 370.00
  • EUR 829.00
  • 1 g
  • 5 g

Alkyne-PEG3-Alkyne

20-abx186246
  • EUR 537.00
  • EUR 829.00
  • 1 g
  • 5 g

OH-PEG3-CH2CH2COOtBu

20-abx186258
  • EUR 244.00
  • EUR 439.00
  • 1 g
  • 5 g

Biotin-PEG3-Azide

abx186382-1g 1 g
EUR 787

Methyl-PEG3-MS

abx186609-250mg 250 mg
EUR 439

NH2-PEG3-NH2

20-abx186613
  • EUR 300.00
  • EUR 606.00
  • 1 g
  • 5 g

NH2-PEG3-COOH

20-abx186616
  • EUR 537.00
  • EUR 1595.00
  • 1 g
  • 5 g

Bromo-PEG3-azide

20-abx186630
  • EUR 370.00
  • EUR 746.00
  • 0.5 g
  • 1 g

Azido-PEG3-FLAG

H-7924.0500 0.5mg
EUR 383
Description: Sum Formula: C50H75N13O24

Azido-PEG3-FLAG

H-7924.1000 1.0mg
EUR 618
Description: Sum Formula: C50H75N13O24

PEG3 Blocking Peptide

AF9152-BP 1mg
EUR 195

Paternally Expressed 3 (PEG3) Antibody

20-abx013786
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Paternally Expressed 3 (PEG3) Antibody

20-abx323448
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Paternally Expressed 3 (PEG3) Antibody

abx331093-100ul 100 ul
EUR 425

NH2-PEG3-C1-Boc

HY-128801 100mg
EUR 131

Bis-PEG3-NHS Ester

ADC-L-120 unit Ask for price

Fmoc-nh-peg3-ch2cooh

20-abx180768
  • EUR 495.00
  • EUR 4114.00
  • EUR 1274.00
  • 1 g
  • 25 g
  • 5 g

Boc-NH-PEG3-NH2

20-abx180877
  • EUR 551.00
  • EUR 1219.00
  • 1 g
  • 5 g

Human PEG3 shRNA Plasmid

20-abx953456
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Mouse PEG3 shRNA Plasmid

20-abx971994
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

PEG3-tetrazine, 1 g

1978-1g 1 g
EUR 661

PEG3-tetrazine, 250 mg

1978-250mg 250 mg
EUR 305

N3-PEG3-vc-PAB-MMAE

HY-100874 5mg
EUR 1221

N3-PEG3-C2-NHS ester

HY-126528 500mg
EUR 3264

Pomalidomide-PEG3-C2-NH2 (TFA)

HY-128716A 2g
EUR 5675

NHPI-PEG3-C2-Pfp ester

HY-130092 100mg
EUR 843

NHPI-PEG3-C2-NHS ester

HY-130093 100mg
EUR 843

NH2-PEG3-C2-NH-Boc

HY-42776 100mg
EUR 108

Peg3 ORF Vector (Mouse) (pORF)

ORF053769 1.0 ug DNA
EUR 1572

PEG3 ORF Vector (Human) (pORF)

ORF027601 1.0 ug DNA
EUR 659

PEG3 dicarboxylic acid, 10 g

1715-10g 10 g
EUR 910

PEG3 dicarboxylic acid, 1 g

1715-1g 1 g
EUR 353

PEG3 dicarboxylic acid, 5 g

1715-5g 5 g
EUR 613

Alkyne-PEG3-COOH, 1 g

1743-1g 1 g
EUR 349

Alkyne-PEG3-COOH, 5 g

1743-5g 5 g
EUR 661

Azide-PEG3-Azide, 1 g

207-1g 1 g
EUR 101

Azide-PEG3-Azide, 5 g

207-5g 5 g
EUR 320

Alkyne-PEG3-OH, 1 g

418-1g 1 g
EUR 93

Alkyne-PEG3-OH, 5 g

418-5g 5 g
EUR 230

Biotin PEG3 azide, 10 mg

C3730 10 mg
EUR 60

Biotin PEG3 azide, 25 mg

D3730 25 mg
EUR 97

Biotin PEG3 azide, 50 mg

E3730 50 mg
EUR 130

Biotin PEG3 azide, 100 mg

F3730 100 mg
EUR 156

Azide-PEG3-Amine, 1 g

218-1g 1 g
EUR 93

Azide-PEG3-Amine, 5 g

218-5g 5 g
EUR 230

(S,R,S)-AHPC-PEG3-N3

HY-103598 2g
EUR 5675

(S,R,S)-AHPC-PEG3-NH2

HY-103602A 1g
EUR 3896

Thalidomide-O-amido-PEG3-C2-NH2

HY-107440 2g
EUR 5675

Ald-Ph-amido-PEG3-C-COOH

HY-130098 100mg
EUR 578

Ald-Ph-amido-PEG3-C1-Boc

HY-130100 100mg
EUR 843

TMP-PEG3-amine, trifluoroacetic acid salt

91056 1MG
EUR 195
Description: Minimum order quantity: 1 unit of 1MG

PEG3 sgRNA CRISPR Lentivector set (Human)

K1626501 3 x 1.0 ug
EUR 339

Peg3 sgRNA CRISPR Lentivector set (Mouse)

K4341801 3 x 1.0 ug
EUR 339

PEG3-AS1 ORF Vector (Human) (pORF)

ORF027602 1.0 ug DNA Ask for price

(S,R,S)-AHPC-PEG3-NH2 (hydrochloride)

HY-103602 25mg
EUR 234

Thalidomide-O-amido-PEG3-C2-NH2 (TFA)

HY-103611 2g
EUR 5675

Ald-Ph-amido-PEG3-C2-Pfp ester

HY-130102 100mg
EUR 843

PEG3 sgRNA CRISPR Lentivector (Human) (Target 1)

K1626502 1.0 ug DNA
EUR 154

PEG3 sgRNA CRISPR Lentivector (Human) (Target 2)

K1626503 1.0 ug DNA
EUR 154

PEG3 sgRNA CRISPR Lentivector (Human) (Target 3)

K1626504 1.0 ug DNA
EUR 154

Peg3 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4341802 1.0 ug DNA
EUR 154

Peg3 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4341803 1.0 ug DNA
EUR 154

Peg3 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4341804 1.0 ug DNA
EUR 154

Peg3 3'UTR GFP Stable Cell Line

TU166185 1.0 ml Ask for price

Peg3 3'UTR Luciferase Stable Cell Line

TU116185 1.0 ml Ask for price

 

 

SUMO4 small interfering RNA attenuates invasion and migration through the JAK2/STAT3 pathway in non-small cell lung most cancers cells

 

  • Small ubiquitin-like modifier 4 (SUMO4) is the most recent member of the sumoylation household, which boosts the steadiness of protein, regulates the distribution and localization of the protein, and impacts the transcription exercise of the protein. Nevertheless, the function of SUMO4 in non-small cell lung most cancers (NSCLC) has not but been reported.
  • The current research first demonstrated that SUMO4 was upregulated in quite a lot of tissues from sufferers with NSCLC. Immunohistochemistry was carried out to display the expression degree of SUMO4 in lung most cancers tumor tissues. Following the transfection, The EMT standing and signaling pathway activation regulated by SUMO4-siRNA was assessed by western blotting.
  • The Transwell and wound therapeutic assays had been carried out to research the regulatory impact of SUMO4-siRNA on cell migration and invasion. Cell Counting Equipment-Eight assay was carried out to research whether or not SUMO4-siRNA affected the chemosensitivity of the NSCLC cells to cisplatin. Statistical evaluation of immunohistochemical outcomes from the tissues confirmed that the overexpression of SUMO4 was considerably related to intercourse, tumor kind, historical past of smoking, T stage and poor prognosis.
  • It was additionally recognized that SUMO4 small interfering RNA attenuated invasion and migration in NSCLC cell traces, as effectively chemosensitivity to cisplatin through the inhibition of the JAK2/STAT3 pathway. In conclusion, SUMO4 might play an essential function within the poor prognosis of sufferers with NSCLC. The current research signifies that SUMO4 could also be a possible therapeutic goal for NSCLC.

 

Low-cost RNA extraction technique for extremely scalable transcriptome research

 

RNA extraction has been improved by integration of quite a lot of supplies within the protocol, akin to phenol, guanidine thiocyanate, and silica, in line with the case-specific calls for. Nevertheless, few strategies have been designed for high-throughput RNA preparation for large-scale transcriptome research. On this research, we established a high-throughput guanidinium thiocyanate and isopropyl alcohol based mostly RNA extraction technique (HighGI).

HighGI relies on easy and phenol-free do-it-yourself buffers and the associated fee is considerably decrease than a column-based business package. We demonstrated that the standard and amount of RNA extracted with HighGI had been corresponding to these extracted with a typical phenol/chloroform-based technique and a column-based business package. HighGI retained small RNAs lower than 200 bp, that are misplaced with a business column-based package.

We additionally demonstrated that HighGI is quickly relevant to semi-automated RNA extraction. HighGI permits high-throughput RNA extraction for large-scale RNA preparation with excessive yield and high quality.

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

Human Chorionic Gonadotropin Alpha Polypeptide (CGa) ELISA Kit

DLR-CGa-Hu-48T 48T
EUR 498
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Chorionic Gonadotropin Alpha Polypeptide (CGa) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Chorionic Gonadotropin Alpha Polypeptide (CGa) ELISA Kit

DLR-CGa-Hu-96T 96T
EUR 647
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Chorionic Gonadotropin Alpha Polypeptide (CGa) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Chorionic Gonadotropin Alpha Polypeptide (CGa) ELISA Kit

RD-CGa-Hu-48Tests 48 Tests
EUR 500

Human Chorionic Gonadotropin Alpha Polypeptide (CGa) ELISA Kit

RD-CGa-Hu-96Tests 96 Tests
EUR 692

Human Chorionic Gonadotropin Alpha Polypeptide (CGa) ELISA Kit

RDR-CGa-Hu-48Tests 48 Tests
EUR 522

Human Chorionic Gonadotropin Alpha Polypeptide (CGa) ELISA Kit

RDR-CGa-Hu-96Tests 96 Tests
EUR 724

CGA Antibody

32250-100ul 100ul
EUR 252

CGA Antibody

1-CSB-PA131153
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against CGA. Recognizes CGA from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

CGA Antibody

1-CSB-PA292680
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against CGA. Recognizes CGA from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

CGA Antibody

CSB-PA005293KA01HU-
EUR 335
Description: A polyclonal antibody against CGA. Recognizes CGA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CGA Antibody

CSB-PA005293KA01HU-100ul 100ul
EUR 389
Description: A polyclonal antibody against CGA. Recognizes CGA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CGA Antibody

DF6371 200ul
EUR 304
Description: CGA Antibody detects endogenous levels of total CGA.

CGA Antibody

ABD6371 100 ug
EUR 438

CgA antibody

10R-2291 1 mL
EUR 584
Description: Mouse monoclonal CgA antibody

CGA Conjugated Antibody

C32250 100ul
EUR 397

CgA/ Rat CgA ELISA Kit

ELA-E1212r 96 Tests
EUR 886

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCA1060-250 250uL
EUR 383
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), APC conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC811060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF680R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC811060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF680R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCAP1060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCAP1060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCB1060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Biotin conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCB1060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Biotin conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC471060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF647 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC471060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF647 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC551060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF555 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC551060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF555 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC431060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF543 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC431060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF543 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC881060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF488A conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC881060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF488A conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC941060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF594 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC941060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF594 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCP1060-250 250uL
EUR 383
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), PerCP conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC041060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF405S conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC041060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF405S conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCR1060-250 250uL
EUR 383
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), RPE conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNUB1060-100 100uL
EUR 209
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Concentration: 0.2mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNUB1060-500 500uL
EUR 458
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Concentration: 0.2mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC681060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF568 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC681060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF568 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC701060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF770 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC701060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF770 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC051060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF405M conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC051060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF405M conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC611060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF660R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC611060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF660R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC401060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF640R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC401060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF640R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC801060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF680 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNC801060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), CF680 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCH1060-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNCH1060-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA414 + CGA/777 + CGA/798) Antibody

BNUM1060-50 50uL
EUR 395
Description: Primary antibody against Chromogranin A(CGA414 + CGA/777 + CGA/798), 1mg/mL

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 280

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

CGA siRNA

20-abx911610
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

CGA siRNA

20-abx911611
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

Chromogranin A(CGA/414) Antibody

BNCA0414-250 250uL
EUR 383
Description: Primary antibody against Chromogranin A(CGA/414), APC conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCAP0414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCAP0414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC810414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF680R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC810414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF680R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC880414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF488A conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC880414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF488A conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCB0414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), Biotin conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCB0414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), Biotin conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC550414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF555 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC550414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF555 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC430414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF543 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC430414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF543 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC470414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF647 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC470414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF647 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC940414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF594 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC940414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF594 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCP0414-250 250uL
EUR 383
Description: Primary antibody against Chromogranin A(CGA/414), PerCP conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC040414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF405S conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC040414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF405S conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC050414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF405M conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC050414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF405M conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCR0414-250 250uL
EUR 383
Description: Primary antibody against Chromogranin A(CGA/414), RPE conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNUB0414-100 100uL
EUR 209
Description: Primary antibody against Chromogranin A(CGA/414), Concentration: 0.2mg/mL

Chromogranin A(CGA/414) Antibody

BNUB0414-500 500uL
EUR 458
Description: Primary antibody against Chromogranin A(CGA/414), Concentration: 0.2mg/mL

Chromogranin A(CGA/414) Antibody

BNC680414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF568 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC680414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF568 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC700414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF770 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC700414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF770 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC800414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF680 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC800414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF680 conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC400414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF640R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC400414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF640R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC610414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), CF660R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNC610414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), CF660R conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCH0414-100 100uL
EUR 199
Description: Primary antibody against Chromogranin A(CGA/414), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNCH0414-500 500uL
EUR 544
Description: Primary antibody against Chromogranin A(CGA/414), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Chromogranin A(CGA/414) Antibody

BNUM0414-50 50uL
EUR 395
Description: Primary antibody against Chromogranin A(CGA/414), 1mg/mL